Prestige Consumer Healthcare (NYSE:PBH) Reaches New 12-Month Low After Earnings Miss

Prestige Consumer Healthcare Inc. (NYSE:PBH)’s share price reached a new 52-week low during mid-day trading on Friday after the company announced weaker than expected quarterly earnings. The stock traded as low as $64.41 and last traded at $64.83, with a volume of 82031 shares traded. The stock had previously closed at $67.61.

The company reported $0.95 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.01 by ($0.06). Prestige Consumer Healthcare had a net margin of 19.02% and a return on equity of 12.69%. The company had revenue of $249.53 million during the quarter, compared to analyst estimates of $260.71 million. During the same quarter last year, the firm earned $0.90 EPS. The business’s revenue was down 6.6% on a year-over-year basis.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on PBH shares. Canaccord Genuity Group dropped their target price on Prestige Consumer Healthcare from $105.00 to $100.00 and set a “buy” rating on the stock in a research report on Friday. Wall Street Zen cut Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday. Finally, Royal Bank Of Canada upgraded Prestige Consumer Healthcare to a “hold” rating in a report on Thursday, May 8th. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $93.33.

Institutional Trading of Prestige Consumer Healthcare

A number of large investors have recently made changes to their positions in PBH. UMB Bank n.a. boosted its holdings in shares of Prestige Consumer Healthcare by 81.8% during the second quarter. UMB Bank n.a. now owns 320 shares of the company’s stock worth $26,000 after purchasing an additional 144 shares during the last quarter. Caitong International Asset Management Co. Ltd boosted its holdings in shares of Prestige Consumer Healthcare by 312.5% during the second quarter. Caitong International Asset Management Co. Ltd now owns 330 shares of the company’s stock worth $26,000 after purchasing an additional 250 shares during the last quarter. Maseco LLP acquired a new stake in shares of Prestige Consumer Healthcare during the second quarter worth $27,000. Opal Wealth Advisors LLC acquired a new stake in shares of Prestige Consumer Healthcare during the first quarter worth $38,000. Finally, Geneos Wealth Management Inc. boosted its holdings in shares of Prestige Consumer Healthcare by 92.8% during the first quarter. Geneos Wealth Management Inc. now owns 559 shares of the company’s stock worth $48,000 after purchasing an additional 269 shares during the last quarter. Institutional investors and hedge funds own 99.95% of the company’s stock.

Prestige Consumer Healthcare Stock Down 3.0%

The firm has a fifty day moving average price of $79.26 and a 200-day moving average price of $82.02. The company has a quick ratio of 2.82, a current ratio of 4.38 and a debt-to-equity ratio of 0.55. The firm has a market cap of $3.24 billion, a price-to-earnings ratio of 15.40, a PEG ratio of 2.03 and a beta of 0.43.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.